• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者中用于诊断周围神经病变的新型汗腺运动功能指标测试(神经垫)与振动觉阈值及临床检查的比较

A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.

作者信息

Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E

机构信息

Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Dragana, Alexandroupolis, Greece.

出版信息

Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):135-8. doi: 10.1055/s-2007-984455. Epub 2007 Dec 20.

DOI:10.1055/s-2007-984455
PMID:18095233
Abstract

UNLABELLED

Peripheral neuropathy remains a major cause of morbidity and is a cardinal factor in the pathogenesis of diabetic foot ulceration. The aim of the present study was to compare the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold (VPT) and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. This study included 154 type 2 diabetic patients (76 men) with a mean age of 64.3+/-7.3 years and a mean diabetes duration of 12.8+/-4.3 years. Neuropathy was diagnosed clinically using the Neuropathy Disability Score (NDS). The VPT was measured with a neurothesiometer, values > 25Volts being classified as abnormal. Sudomotor function was evaluated by the indicator test. Sensitivity of the indicator test for neuropathy was 97.8% and specificity was 67.2%. Sensitivity and specificity of VPT for neuropathy were 78.9% and 85.9% respectively. A significant correlation was shown between time to colour change of the indicator test and VPT (rs=0.889, p<0.001).

CONCLUSIONS

Both the indicator test and the VPT have a high sensitivity for neuropathy. Sensitivity is higher with the indicator test, but specificity is higher with VPT. Time until complete colour change of the indicator test shows a positive correlation with VPT. Thus, the indicator test appears to be a useful additional diagnostic tool of neuropathy, particularly suitable for screening and self-examination, in type 2 diabetes. The correlation between time to colour change of the indicator test and VPT is interesting and merits investigation in a prospective study.

摘要

未标记

周围神经病变仍然是发病的主要原因,并且是糖尿病足溃疡发病机制中的一个关键因素。本研究的目的是比较用于评估汗腺运动功能的新指标测试(神经垫)与振动觉阈值(VPT)以及临床检查在2型糖尿病患者周围神经病变诊断中的作用。本研究纳入了154例2型糖尿病患者(76例男性),平均年龄为64.3±7.3岁,平均糖尿病病程为12.8±4.3年。使用神经病变残疾评分(NDS)进行临床神经病变诊断。用神经感觉测量仪测量VPT,值>25伏特被分类为异常。通过指标测试评估汗腺运动功能。指标测试对神经病变的敏感性为97.8%,特异性为67.2%。VPT对神经病变的敏感性和特异性分别为78.9%和85.9%。指标测试颜色变化时间与VPT之间存在显著相关性(rs = 0.889,p<0.001)。

结论

指标测试和VPT对神经病变均具有高敏感性。指标测试的敏感性更高,但VPT的特异性更高。指标测试完全变色的时间与VPT呈正相关。因此,指标测试似乎是一种有用的神经病变辅助诊断工具,特别适用于2型糖尿病的筛查和自我检查。指标测试颜色变化时间与VPT之间的相关性很有趣,值得在前瞻性研究中进行调查。

相似文献

1
A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.2型糖尿病患者中用于诊断周围神经病变的新型汗腺运动功能指标测试(神经垫)与振动觉阈值及临床检查的比较
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):135-8. doi: 10.1055/s-2007-984455. Epub 2007 Dec 20.
2
Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.一种用于评估泌汗运动功能的新型指标测试(神经垫)在2型糖尿病患者周围神经病变诊断中的应用
Exp Clin Endocrinol Diabetes. 2005 Apr;113(4):195-8. doi: 10.1055/s-2005-837735.
3
Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients.使用新型指标测试(神经垫)评估2型糖尿病患者神经病变的分期严重程度。
Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):58-61. doi: 10.1055/s-2007-955098.
4
Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.在临床实践中使用简单的躯体检查和一种新的自主神经(神经垫)检查诊断糖尿病性神经病变。
Exp Clin Endocrinol Diabetes. 2010 Apr;118(4):226-33. doi: 10.1055/s-0030-1247565. Epub 2010 Mar 3.
5
Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.预测 2 型糖尿病伴增殖性视网膜病变患者振动感知阈值的因素。
Postgrad Med J. 2011 Oct;87(1032):658-63. doi: 10.1136/pgmj.2010.104216.
6
Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.一种新型指标检测(神经垫)对2型糖尿病患者周围神经病变诊断的敏感性和特异性:与临床检查及神经传导研究的比较
J Diabetes Complications. 2007 Nov-Dec;21(6):353-8. doi: 10.1016/j.jdiacomp.2006.08.003.
7
A prospective study on the use of the indicator test Neuropad® for the early diagnosis of peripheral neuropathy in type 2 diabetes.关于使用指示测试Neuropad®对2型糖尿病周围神经病变进行早期诊断的前瞻性研究。
Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):122-5. doi: 10.1055/s-0030-1261934. Epub 2010 Aug 5.
8
Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.无创定量评估汗腺功能用于外周糖尿病性神经病变评估。
Diabetes Metab. 2011 Dec;37(6):527-32. doi: 10.1016/j.diabet.2011.05.003. Epub 2011 Jun 28.
9
Quantitative vibration perception threshold in assessing diabetic neuropathy: is the cut-off value lower for Indian subjects? [Q-VADIS Study].评估糖尿病性神经病变时的定量振动觉阈值:印度受试者的临界值是否更低?[Q-VADIS研究]
Diabetes Metab Syndr. 2012 Apr-Jun;6(2):85-9. doi: 10.1016/j.dsx.2012.08.002. Epub 2012 Aug 27.
10
[Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].[四种简易方法诊断糖尿病周围神经病变的评估]
Zhonghua Yi Xue Za Zhi. 2006 Oct 17;86(38):2707-10.

引用本文的文献

1
Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres.糖尿病周围神经病变的早期检测:聚焦于小神经纤维
Diagnostics (Basel). 2021 Jan 24;11(2):165. doi: 10.3390/diagnostics11020165.
2
New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine.糖尿病神经病变的新视角:从外周到大脑,呼吁早期检测与精准医学。
Front Endocrinol (Lausanne). 2020 Jan 17;10:929. doi: 10.3389/fendo.2019.00929. eCollection 2019.
3
Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy.
神经垫设备作为早期糖尿病周围神经病变筛查工具的成本效益分析。
Eur J Health Econ. 2020 Apr;21(3):335-349. doi: 10.1007/s10198-019-01134-2. Epub 2019 Nov 12.
4
Factors associated with diabetic foot among type 2 diabetes in Northern area of Saudi Arabia: a descriptive study.沙特阿拉伯北部地区2型糖尿病患者糖尿病足的相关因素:一项描述性研究。
BMC Res Notes. 2019 Jan 22;12(1):51. doi: 10.1186/s13104-019-4088-4.
5
Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy.糖尿病周围神经病变诊断策略的最新进展。
Endocrinol Metab (Seoul). 2016 Jun;31(2):230-8. doi: 10.3803/EnM.2016.31.2.230. Epub 2016 May 27.
6
Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus.腓肠神经自动神经传导研究在2型糖尿病患者周围神经病变诊断中的评估
Arch Med Sci. 2016 Apr 1;12(2):390-3. doi: 10.5114/aoms.2016.59265. Epub 2016 Apr 12.
7
Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy.神经垫的自动定量分析提高了其在糖尿病神经病变患者中的诊断能力。
J Diabetes Res. 2015;2015:847854. doi: 10.1155/2015/847854. Epub 2015 May 12.
8
The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy.Neuropad评估大、小纤维糖尿病性神经病变的诊断准确性。
Diabet Med. 2014 Dec;31(12):1673-80. doi: 10.1111/dme.12536. Epub 2014 Jul 14.
9
Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes.神经垫检测诊断 2 型糖尿病远端对称性多发性神经病的准确性。
Diabetes Care. 2011 Jun;34(6):1378-82. doi: 10.2337/dc10-2205. Epub 2011 Apr 19.
10
Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function.筛查溃疡高危足:躯体和自主神经功能检查。
Curr Diab Rep. 2011 Aug;11(4):294-301. doi: 10.1007/s11892-011-0192-0.